Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
mSphere ; 5(2)2020 03 11.
Article in English | MEDLINE | ID: mdl-32161144

ABSTRACT

Surveillance of 10 hospitals and a regional public health laboratory in Myanmar identified 31 isolates of carbapenem-resistant Enterobacter cloacae complex harboring blaNDM-type Of these isolates, 19 were highly resistant to aminoglycosides and harbored one or more genes encoding 16S rRNA methylases, including armA, rmtB, rmtC, and/or rmtE Of the 19 isolates, 16 were Enterobacter xiangfangensis ST200, with armA on the chromosome and a plasmid harboring blaNDM-1 and rmtC, indicating that these isolates were clonally disseminated nationwide in Myanmar.IMPORTANCE The emergence of multidrug-resistant E. cloacae complex has become a public health threat worldwide. E. xiangfangensis is a recently classified species belonging to E. cloacae complex. Here, we report a clonal dissemination of multidrug-resistant E. xiangfangensis ST200 producing two types of New Delhi metallo-ß-lactamase (NDM-type MBL), NDM-1 and -4, and three types of 16S rRNA methylases, ArmA, RmtC, and RmtE, in hospitals in Myanmar. The observation of these multidrug-resistant E. xiangfangensis ST200 isolates stresses the urgency to continue molecular epidemiological surveillance of these pathogens in Myanmar and in South Asian countries.


Subject(s)
Aminoglycosides/pharmacology , Carbapenems/pharmacology , Drug Resistance, Multiple, Bacterial , Enterobacter cloacae/drug effects , Methyltransferases/genetics , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Enterobacter/drug effects , Enterobacter/genetics , Enterobacter cloacae/enzymology , Enterobacter cloacae/genetics , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests , Myanmar/epidemiology , Phylogeny , RNA, Ribosomal, 16S/genetics
2.
J Glob Antimicrob Resist ; 22: 122-125, 2020 09.
Article in English | MEDLINE | ID: mdl-32084608

ABSTRACT

OBJECTIVE: The aim of this study was to clarify the genetic and epidemiological properties of multidrug-resistant Acinetobacter baumannii in medical settings in Myanmar. METHODS: A total of 45 A. baumannii clinical isolates were obtained in medical settings in Myanmar. The whole genomes were sequenced by a next generation sequencer, and the phylogenetic tree was constructed from single nucleotide polymorphism concatemers. Multilocus sequence types were deduced and drug resistance genes were identified. RESULTS: Thirty-eight MDR Acinetobacter baumannii isolates were obtained from seven hospitals in Myanmar. The majority of MDR A. baumannii isolates belonged to ST2. Of the 38 isolates, 5 harbored blaNDM-1, and 28 did armA or armA2 CONCLUSIONS: A. baumannii ST2 producing 16S rRNA methylase ArmA has been spreading in medical settings in Myanmar.


Subject(s)
Acinetobacter baumannii , Acinetobacter baumannii/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Drug Resistance, Multiple, Bacterial/genetics , Hospitals , Microbial Sensitivity Tests , Molecular Epidemiology , Myanmar/epidemiology , Phylogeny , RNA, Ribosomal, 16S , beta-Lactamases/genetics
3.
Diagn Microbiol Infect Dis ; 95(4): 114882, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31495528

ABSTRACT

CRE-JU is a novel selective agar for carbapenem-resistant Enterobacteriaceae that contains ceftazidime, cloxacillin, meropenem, and vancomycin. This study evaluated the ability of 63 carbapenem-resistant isolates and 53 non-carbapenem-resistant Enterobacteriaceae strains clinically isolated in Japan, Myanmar, Nepal, and Vietnam to grow on CRE-JU. CRE-JU showed 92.1% sensitivity and 100% specificity for detecting carbapenem-resistant Enterobacteriaceae compared with dug susceptibility profiles.


Subject(s)
Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Culture Media/chemistry , Enterobacteriaceae Infections/microbiology , Microbial Sensitivity Tests/methods , Agar , Anti-Bacterial Agents/analysis , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Carbapenem-Resistant Enterobacteriaceae/drug effects , Carbapenem-Resistant Enterobacteriaceae/enzymology , Carbapenem-Resistant Enterobacteriaceae/metabolism , Enterobacteriaceae/drug effects , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/metabolism , Fermentation , Humans , Lactose/metabolism , Microbial Sensitivity Tests/instrumentation , Sensitivity and Specificity , beta-Lactamases/metabolism
4.
BMC Infect Dis ; 19(1): 565, 2019 Jun 28.
Article in English | MEDLINE | ID: mdl-31253101

ABSTRACT

BACKGROUND: To detect carbapenemase-producing Gram-negative bacteria in bacterial laboratories at medical settings, a new immunochromatographic assay for New Delhi metallo-ß-lactamases (NDMs) was developed. METHODS: The immunochromatographic assay for New Delhi metallo-ß-lactamases producers was developed using rat monoclonal antibodies against NDMs. The assessment was performed using 350 isolates of Gram-negative bacteria, including Acinetobacter baumannii (51 isolates), Enterobacteriaceae (163 isolates), and Pseudomonas aeruginosa (136 isolates) obtained from 2015 to 2017 in medical settings in Myanmar. Of them, 302 isolates were resistant to carbapenems, including imipenem and/or meropenem. The blaNDM genes were identified by PCR and sequencing. RESULTS: Of the 350 clinical isolates tested, 164 (46.9%) (60 isolates of Escherichia coli, 51 isolates of Klebsiella pneumoniae, 25 isolates of Enterobacter cloacae, 23 isolates of P. aeruginosa, and 5 isolates of A. baumannii) were positive on this assay, and all the positive isolates harbored genes encoding NDM-1, - 4, - 5 and - 7. The remaining 186 (53.1%) isolates negative on the assay did not harbor genes encoding NDMs. The assay had a specificity of 100% and a sensitivity of 100%. The assessment revealed that more than 90% of carbapenem-resistant Enterobacteriaceae produced NDMs. CONCLUSIONS: The immunochromatographic assay is an easy-to-use and reliable kit for detection of NDMs-producing Gram-negative bacteria. The assay revealed that NDM-producing Enterobacteriaceae isolates are wide-spread in medical settings in Myanmar.


Subject(s)
Gram-Negative Bacteria/isolation & purification , Immunoassay/methods , beta-Lactamases/immunology , Acinetobacter baumannii/enzymology , Acinetobacter baumannii/isolation & purification , Animals , Anti-Bacterial Agents/pharmacology , Antibodies, Monoclonal/immunology , Drug Resistance, Bacterial , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Gram-Negative Bacteria/enzymology , Gram-Negative Bacteria/genetics , Humans , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Myanmar , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/isolation & purification , Rats , beta-Lactamases/genetics , beta-Lactamases/metabolism
5.
Article in English | MEDLINE | ID: mdl-31138570

ABSTRACT

Pseudomonas asiatica is a recently proposed species of the genus Pseudomonas This study describes eight isolates of carbapenem-resistant P. asiatica harboring blaNDM-1 and blaVIM-2, genes encoding metallo-ß-lactamase (MBL). These isolates were obtained from urine samples of patients hospitalized in Myanmar. These isolates were resistant to carbapenems but susceptible to colistin. All eight isolates were positive for a carbapenemase inactivation method, CIMTrisII, and seven were positive on an immunochromatographic assay for NDM-type MBL. One isolate was highly resistant to aminoglycosides. Whole-genome sequencing showed that seven isolates harbored blaNDM-1 and one harbored blaVIM-2, with these genes located on the chromosome. One isolate harbored blaNDM-1 and rmtC, a gene encoding 16S rRNA methylase. Five types of genomic environments surrounding blaNDM-1 and blaVIM-2 were detected in these eight isolates, with four isolates having the same type. These data indicate that P. asiatica isolates harboring genes encoding carbapenemases, including blaNDM-1 and blaVIM-2, are spreading in medical settings in Myanmar.


Subject(s)
Carbapenems/pharmacology , Drug Resistance, Bacterial/genetics , Pseudomonas/drug effects , Pseudomonas/genetics , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests/methods , Myanmar , RNA, Ribosomal, 16S/genetics
6.
Article in English | MEDLINE | ID: mdl-30803967

ABSTRACT

The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa has become a serious worldwide medical problem. This study was designed to clarify the genetic and epidemiological properties of MDR P. aeruginosa strains isolated from hospitals in Myanmar. Forty-five MDR P. aeruginosa isolates obtained from different patients in seven hospitals in Myanmar were screened using the broth microdilution method. The whole genomes of the MDR isolates were sequenced using a MiSeq platform (Illumina). Phylogenetic trees were constructed from single nucleotide polymorphism concatemers. Multilocus sequence types were deduced, and drug resistance genes were identified. Of the 45 isolates, 38 harbored genes encoding carbapenemases, including DIM-1, IMP-1, NDM-1, VIM-2, and VIM-5, and 9 isolates had genes encoding 16S rRNA methylases, including RmtB, RmtD3, RmtE, and RmtF2. Most MDR P. aeruginosa strains isolated in Myanmar belonged to sequence type 1047 (ST1047). This is the first molecular epidemiological analysis of MDR P. aeruginosa clinical isolates in Myanmar. These findings strongly suggest that P. aeruginosa ST1047 strains harboring carbapenemases, including DIM-, IMP-, NDM-, and VIM-type metallo-ß-lactamases, have been spreading throughout medical settings in Myanmar.


Subject(s)
Pseudomonas aeruginosa/drug effects , Bacterial Proteins/classification , Bacterial Proteins/genetics , Hospitals , Microbial Sensitivity Tests , Molecular Epidemiology , Multilocus Sequence Typing , Myanmar , Phylogeny , Pseudomonas aeruginosa/genetics , RNA, Ribosomal, 16S/genetics , beta-Lactamases/classification , beta-Lactamases/genetics
7.
Int J Syst Evol Microbiol ; 69(5): 1361-1368, 2019 May.
Article in English | MEDLINE | ID: mdl-30810522

ABSTRACT

A novel Gram-negative, aerobic, rod-shaped, non-spore-forming bacterial strain, RYU5T, was isolated from a stool sample of an inpatient at a hospital in Okinawa, Japan. The optimal growth temperature of RYU5T was 30 °C. Phylogenetic analysis based on the sequences of housekeeping genes, including the 16S rRNA, rpoB, rpoD and gyrB genes, showed that RYU5T was a member of the Pseudomonas putida group and was located close to Pseudomonas monteilii and P. putida. Whole-genome comparisons, using average nucleotide identity and digital DNA-DNA hybridization, confirmed that strain RYU5T should be classified as a novel species of Pseudomonas. Phenotypic characterization tests showed that utilization of d-mannose, d-serine, l-arabinose and d-fructose could distinguish this strain from other related species of the genus Pseudomonas. Based on genetic and phenotypic evidence, strain RYU5T should be classified as a novel species, for which the name Pseudomonas asiatica sp. nov. is proposed. The type strain is RYU5T (=DSM 107182T, =JCM 32716T), with a DNA G+C content of 62.25 mol%.


Subject(s)
Feces/microbiology , Phylogeny , Pseudomonas/classification , Bacterial Typing Techniques , Base Composition , DNA, Bacterial/genetics , Fatty Acids/chemistry , Female , Genes, Bacterial , Humans , Japan , Male , Myanmar , Nucleic Acid Hybridization , Pseudomonas/isolation & purification , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
8.
J Med Microbiol ; 68(2): 124-131, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30526741

ABSTRACT

The modified carbapenem inactivation method (mCIM) is a simple phenotypic screening method for detecting carbapenemase production by Enterobacteriaceae and Pseudomonas aeruginosa. We recently developed another modified carbapenem inactivation method (CIMTris), in which carbapenemase is extracted from bacteria with Tris-HCl buffer, to detect carbapenemase production by Acinetobacter and Pseudomonas species. This study describes an improved carbapenem inactivation method, CIMTrisII, for detecting carbapenemase production by Gram-negative pathogens, including Enterobacteriaceae, Acinetobacter and Pseudomonas species. CIMTrisII was different from CIMTris in the concentration of Meropenem disks (5-µg MEM disks vs. 10-µg MEM disks), the inoculum volume of the bacteria (a 5-µl loopful vs. a 10 µl loopful) and the incubation time (1 vs. 2 h). CIMTrisII showed an overall sensitivity of 99.3 % and an overall specificity of 95.0 % for tested isolates. In comparison, CIMTris showed a sensitivity of 96.1 % and a specificity of 96.3 %, and mCIM showed a sensitivity of 67.1 % and a specificity of 100 %. CIMTrisII is thus deemed useful for detecting carbapenemase production by Gram-negative pathogens.


Subject(s)
Acinetobacter/enzymology , Bacterial Proteins/biosynthesis , Carbapenems/antagonists & inhibitors , Enterobacteriaceae/enzymology , Pseudomonas/enzymology , beta-Lactamases/biosynthesis , Acinetobacter/drug effects , Acinetobacter/genetics , Anti-Bacterial Agents/pharmacology , Asia, Southeastern , Bacterial Infections/microbiology , DNA, Bacterial/chemistry , Enterobacteriaceae/drug effects , Enterobacteriaceae/genetics , Humans , Imipenem/pharmacology , Japan , Meropenem/pharmacology , Microbial Sensitivity Tests , Nepal , Pseudomonas/drug effects , Pseudomonas/genetics , Sensitivity and Specificity , Sequence Analysis, DNA , Time Factors
10.
Toxins (Basel) ; 9(8)2017 08 04.
Article in English | MEDLINE | ID: mdl-28777321

ABSTRACT

Asymptomatic carriers of toxigenic Staphylococcus aureus are potential source of diseases, including food poisoning. Toxigenic potential and genetic traits of colonizing S. aureus were investigated for 563 healthy food handlers in Myanmar. Carriage of S. aureus was found in 110 individuals (19.5%), and a total of 144 S. aureus isolates were recovered from nasal cavities (110 isolates) and hands (34 isolates). Panton-Valentine leucocidin genes (pvl) were detected in 18 isolates (12.5%), among which 11 isolates were classified into coa-VIa, agr type III, and ST1930 (CC96) that had been also detected in pvl-positive clinical isolates in Myanmar. A pvl-positive, ST2250 nasal isolate was identified as S. argenteus, a novel coagulase-positive staphylococcus species. Toxic shock syndrome toxin-1 (TSST-1) gene was detected in five pvl-negative isolates. All of the 144 isolates harbored at least one of the 21 enterotoxin(-like) gene(s). The most prevalent enterotoxin(-like) gene was selw (98%), followed by selx (97%), sei (28%), sely (28%), sem (26%), sel (24%), and sea and sec (22% each). Considerable genetic diversity with five groups was detected for selw. The present study revealed the relatively high rate of pvl, as well as the wide distribution of enterotoxin(-like) genes among colonizing S. aureus in Myanmar.


Subject(s)
Bacterial Toxins/genetics , Enterotoxins/genetics , Exotoxins/genetics , Food Handling , Leukocidins/genetics , Staphylococcal Infections/microbiology , Staphylococcus/genetics , Staphylococcus/isolation & purification , Superantigens/genetics , Hand/microbiology , Humans , Myanmar/epidemiology , Nasal Cavity/microbiology , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics , Staphylococcal Infections/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...